1. Chromogranin A and neurone‐specific enolase variations during the first 3 months of abiraterone therapy predict outcomes in patients with metastatic castration‐resistant prostate cancer. (19th February 2017) Authors: Fan, Liancheng; Wang, Yanqing; Chi, Chenfei; Pan, Jiahua; Xun, Shangguan; Xin, Zhixiang; Hu, Jianian; Zhou, Lixin; Dong, Baijun; Xue, Wei Journal: BJU international Issue: Volume 120:Number 2(2017) Page Start: 226 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Distinct Response to Platinum-Based Chemotherapy among Patients with Metastatic Castration-Resistant Prostate Cancer Harboring Alterations in Genes Involved in Homologous Recombination. Issue 3 (27th September 2021) Authors: Fan, Liancheng; Fei, Xiaochen; Zhu, Yinjie; Chi, Chenfei; Pan, Jiahua; Sha, Jianjun; Xin, Zhixiang; Gong, Yiming; Du, Xinxing; Wang, Yanqing; Dong, Baijun; Xue, Wei Journal: Journal of urology Issue: Volume 206:Issue 3(2021) Page Start: 630 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Efficacy of neoadjuvant docetaxel + cisplatin chemo-hormonal therapy versus docetaxel chemo-hormonal therapy in patients with locally advanced prostate cancer with germline DNA damage repair gene alterations. (September 2022) Authors: Chi, Chenfei; Liu, Jiazhou; Fan, Liancheng; Zhu, Yinjie; Wang, Yanqing; Sha, Jianjun; Huang, Yiran; Dong, Baijun; Pan, Jiahua; Xue, Wei Journal: Therapeutic advances in medical oncology Issue: Volume 14(2022) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. HOXD13 suppresses prostate cancer metastasis and BMP4‐induced epithelial‐mesenchymal transition by inhibiting SMAD1. Issue 12 (6th March 2021) Authors: Xu, Fan; Shangguan, Xun; Pan, Jiahua; Yue, Zhiying; Shen, Kai; Ji, Yiyi; Zhang, Weiwei; Zhu, Yinjie; Sha, Jianjun; Wang, Yanqing; Fan, Liancheng; Dong, Baijun; Wang, Qi; Xue, Wei Journal: International journal of cancer Issue: Volume 148:Issue 12(2021) Page Start: 3060 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Influence of abiraterone acetate on neuroendocrine differentiation in chemotherapy‐naive metastatic castration‐resistant prostate cancer. Issue 13 (14th August 2017) Authors: Dong, Baijun; Fan, Liancheng; Wang, Yanqing; Chi, Chenfei; Ma, Xiaowei; Wang, Rui; Cai, Wen; Shao, Xiaoguang; Pan, Jiahua; Zhu, Yinjie; Shangguan, Xun; Xin, Zhixiang; Hu, Jianian; Xie, Shaowei; Kang, Xiaonan; Zhou, Lixin; Xue, Wei Journal: Prostate Issue: Volume 77:Issue 13(2017) Page Start: 1373 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Neuroendocrine differentiation markers guide treatment sequence selection in metastatic castration‐resistant prostate cancer. Issue 6 (6th January 2019) Authors: Fan, Liancheng; Yang, Yan; Chi, Chenfei; Ma, Xiaowei; Wang, Rui; Gong, Yiming; Zheng, Hongying; Pan, Jiahua; Zhu, Yinjie; Dong, Baijun; Xue, Wei Journal: Prostate Issue: Volume 79:Issue 6(2019) Page Start: 567 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Prognostic nutritional index predicts initial response to treatment and prognosis in metastatic castration‐resistant prostate cancer patients treated with abiraterone. Issue 12 (28th July 2017) Authors: Fan, Liancheng; Wang, Xiao; Chi, Chenfei; Wang, Yanqing; Cai, Wen; Shao, Xiaoguang; Xu, Fan; Pan, Jiahua; Zhu, Yinjie; Shangguan, Xun; Xin, Zhixiang; Hu, Jianian; Xie, Shaowei; Wang, Rui; Zhou, Lixin; Dong, Baijun; Xue, Wei Journal: Prostate Issue: Volume 77:Issue 12(2017) Page Start: 1233 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Systemic immune‐inflammation index predicts the combined clinical outcome after sequential therapy with abiraterone and docetaxel for metastatic castration‐resistant prostate cancer patients. Issue 4 (29th December 2017) Authors: Fan, Liancheng; Wang, Rui; Chi, Chenfei; Cai, Wen; Zhang, Yong; Qian, Hongyang; Shao, Xiaoguang; Wang, Yanqing; Xu, Fan; Pan, Jiahua; Zhu, Yinjie; Shangguan, Xun; Zhou, Lixin; Dong, Baijun; Xue, Wei Journal: Prostate Issue: Volume 78:Issue 4(2018) Page Start: 250 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Targeted Next-Generation Sequencing Reveals Heterogenous Genomic Features in Viscerally Metastatic Prostate Cancer. Issue 2 (29th August 2021) Authors: Gong, Yiming; Fan, Liancheng; Fei, Xiaochen; Zhu, Yinjie; Du, Xinxing; He, Yuman; Pan, Jiahua; Dong, Baijun; Xue, Wei Journal: Journal of urology Issue: Volume 206:Issue 2(2021) Page Start: 279 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. The prevalence and clinical implication of rare germline deleterious alterations in Chinese patients with prostate cancer: A real‐world multicenter study. Issue 10 (12th October 2021) Authors: Fei, Xiaochen; Fan, Liancheng; Chen, Wei; Chen, Wei; Gong, Yiming; Du, Xinxing; Wang, Yanqing; Zhu, Yinjie; Pan, Jiahua; Wang, Fangqin; Zhao, Wanbing; Liu, Tongtong; Yang, Yining; Dong, Baijun; Xue, Wei Journal: Clinical and translational medicine Issue: Volume 11:Issue 10(2021) Page Start: n/a Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗